Update in the epidemiology, prophylaxis, and treatment of fungal infections in patients with hematologic disorders

Research output: Contribution to journalReview article

10 Scopus citations

Abstract

Invasive fungal infections contribute to the morbidity and mortality of immunosuppressed patients treated for hematologic malignancy and those undergoing hematopoietic cell transplantation. After years of limited advances, the management of fungal infections in these patients is now rapidly evolving. In this update, we will outline changes in the epidemiology of invasive fungal infections, discuss current issues in diagnosis and susceptibility testing, and review the current classes of antifungal drugs, focusing on newly licensed therapies. Data on antifungal prophylaxis, empiric therapy, and treatment of documented invasive fungal infections including single agents and combinations with newly licensed agents will be reviewed with emphasis on their impact on patients with hematologic malignancies.

Original languageEnglish (US)
Pages (from-to)669-680
Number of pages12
JournalLeukemia and Lymphoma
Volume45
Issue number4
DOIs
StatePublished - Apr 1 2004

Keywords

  • Bone marrow transplantation
  • Leukemia lymphoma
  • Mycoses
  • Neutropenia
  • Opportunistic infection

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Update in the epidemiology, prophylaxis, and treatment of fungal infections in patients with hematologic disorders'. Together they form a unique fingerprint.

  • Cite this